Stella Pharma Corp. Hits Day High with 13.24% Surge in Stock Price

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, gaining 13.24% as of March 27, 2026. The stock reached an intraday high of JPY 928.00, marking a notable milestone in its trading performance. Over the past week, Stella Pharma has surged by 45.62%, and its one-month performance shows an impressive increase of 92.36%. Year-to-date, the stock has skyrocketed by 333.99%, significantly outperforming the Japan Nikkei 225, which has seen a modest gain of 6.03% during the same period. Despite these gains, the company faces challenges, including a negative return on equity and a concerning operating profit decline over the past five years. The stock's performance metrics indicate a complex financial landscape, with a market capitalization of JPY 8,066 million and a price-to-book ratio of 2.78. As Stella Pharma continues to navigate its market position, today's performance highlights its volatility and the ongoing dynamics within the biotechnology industry.